Author (year) | Participants (n) [enrolled] | Gender M/F | Age Mean (SD) | Classification | Type I/H | Pathology characteristics | Duration Mean (SD) | ||
---|---|---|---|---|---|---|---|---|---|
Affected side | Right/left | Location of lesion C/SC | |||||||
Geroin C. et al. (2011)29 | n = 30 tDCS (n = 10) Sham (n = 10) Control (n = 10) | tDCS: 8/2 Sham: 6/4 Control: 9/1 | tDCS: 63.6 (6.7) Sham: 63.3 (6.4) Control: 61.1 (6.3) | Chronic | – | – | tDCS: 4/3 Sham: 5/2 Control: 3/4 | tDCS:25.7 (6.0) Sham: 26.7 (5.1) Control: 26.9 (5.8) months | |
Hesse S. et al. (2011)2830 | n = 96 Anodal tDCS (n = 32) Cathodal tDCS (n = 32) Sham (n = 32) | Anodal tDCS: 20/12 Cathodal tDCS: 18/14 Sham: 21/11 | Anodal tDCS: 63.9 (19.5) Cathodal tDCS: 65.4 (8.6) Sham: 65.6 (10.3) | Subacute | Anodal tDCS: 32/0 Cathodal tDCS: 32/0 Sham: 32/0 | Anodal tDCS: 14/18 Cathodal tDCS: 15/17 Sham: 16/16 | Anodal tDCS: 25/7 Cathodal tDCS: 24/8 Sham: 26/6 | Anodal tDCS: 3.4 ± 1.8 Cathodal tDCS: 3.8 ± 1.4 Sham: 3.8 ± 1.5 weeks | |
Danz M. et al. (2013)2931 | n = 8 tDCS (n = 4) Sham (n = 4) | tDCS: 3/1 Sham: 1/3 | tDCS: 64.75 (14.86) Sham: 70.75 (11.14) | Chronic > 12 months | tDCS: 2/2 Sham: 4/0 | tDCS: 0/4 Sham: 0/4 | – | tDCS: 4.78 (4.6) Sham: 3.22 (2.73) years | |
Triccas T. et al. (2015)3032 | n = 23 tDCS (n = 12) Sham (n = 11) | tDCS: 7/5 Sham: 7/4 | tDCS: 62.5 (14.3) Sham: 64.3 (9.94) | Subacute and chronic > 2 months | tDCS: 9/3 Sham: 9/2 | tDCS: 11/2 Sham: 11/0 | tDCS: 3/8 Sham:4/6 | 19.6 (25.7) months | |
Straudi. S et al (2016)3133 | n = 23 tDCS (n = 12) Sham (n = 11) | tDCS: 5/7 Sham: 7/4 | tDCS: 52.7 (16.0) Sham: 64.3 (9.7) | Subacute and chronic | tDCS: 10/2 Sham: 9/2 | tDCS: 3/9 Sham: 5/6 | tDCS: 9/3 Sham: 5/6 | tDSC: 40.7 (35.1) Sham: 78.2 (61.9) weeks | |
Seo HG et al (2017)3234 | n = 21 tDCS (n = 11) Sham (n = 10) | Sham: 7/3 tDCS: 9/2 | Sham: 62.9 ± 8.9 tDCS: 61.1 ± 8.9 | Chronic | Sham: 7/3 tDCS: 9/2 | Sham: 8/2 tDCS: 5/6 | – | Sham: 152.5 ± 122.8 tDCS: 75.5 ± 83.4 months | |
Mazzoleni S et al (2017)3335 | n = 24 tDCS (n = 12) Sham (n = 12) | Sham: 6/6 tDCS: 1/11 | Sham: 75.25 ± 8.01 tDCS: 70.00 ± 12.80 | Subacute | Sham: 11/1 tDCS: 7/5 | Sham: 6/6 tDCS: 6/6 | – | Sham: 24.17 ± 14.02 tDCS:26.58 ± 11.86 days | |
Dehem et al (2018)3436 | n = 21 Crossover | 15/6 | Total: 60.5 (9.5) | Chronic | Total: 15/6 | Total: 11/10 | 14/7 | Total: 38.6 (57.0) months | |
Edwards et al (2019)3537 | n = 82 Robot + tDCS (n = 41) Robot + sham (n = 41) | 50/32 | 67.8 | Chronic | Ischaemic | Right (82) | – | 1317 days 3.6 years | |
Mazzoleni et al (2019)3638 | n = 40 tDCS (n = 20) Sham (n = 20) | Sham: 7/12 tDCS: 8/12 | Sham: 68.74 ± 15.83 tDCS: 67.50 ± 16.30 | Subacute Stroke | Sham: 16/3 tDCS: 13/7 | Sham: 11/8 tDCS: 11/9 | – | 25 ± 7 days |